Loading…
Loading…
Oppenheimer on Thursday initiated coverage of Palisade Bio Inc. (NASDAQ:PALI) , saying the stock offers investors an attractive way to gain exposure to the fast-growing inflammatory bowel disease market.
Is the federal government's clash with Anthropic a warning sign for the entire artificial intelligence ecosystem? Tech strategist and Georgetown adjunct law professor Emily Benson breaks down the regulatory fallout for AI developers and investors.
The AI buildout's real bottleneck is the steel, copper, and chilled water surrounding the GPUs.
A smart beta exchange traded fund, the Inspire Corporate Bond ETF (IBD) debuted on 07/10/2017, and offers broad exposure to the Investment Grade Corporate Bond ETFs category of the market.
AbbVie presents 18 abstracts in Crohn's disease and ulcerative colitis Breadth of data from real-world evidence and clinical trials reinforce risankizumab and upadacitinib efficacy, safety profile, and durability NORTH CHICAGO, Ill., May 5, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the presentation of new data across its gastroenterology portfolio at the 2026 Digestive Disease Week (DDW) Annual Meeting, May 2-5 in Chicago.
KT-579 demonstrated activity comparable or superior to approved and clinically active therapies in preclinical IBD models
Vancouver, British Columbia--(Newsfile Corp. - April 30, 2026) - Aegis Critical Energy Defence Corp. (CSE: QESS) (OTCQB: QESSF) (FSE: JG6) ("Aegis" or the "Company"), a developer of secure and resilient energy systems for critical infrastructure, is pleased to announce that Malahat Energy Systems Inc. ("Malahat Energy" or "MES"), a company in which Aegis holds a 49% ownership interest, has been approved and is now listed in the Government of Canada's Indigenous Business Directory ("IBD"). Malahat Energy's inclusion in the IBD confirms its eligibility to participate in federal procurement opportunities, including contracts that may be competed exclusively among Indigenous businesses under the Procurement Strategy for Indigenous Business (PSIB).
BOISE, Idaho, April 28, 2026 /PRNewswire/ -- Inspire Investing, the world's largest provider of Christian ETFs, reported expense ratio reductions on five of its exchange traded funds. These reductions range from 2.7% to 7.6% for an overall average decrease of 5.3%.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for IBD and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.